Everence Capital Management’s Bio-Techne TECH Stock Holding History

Everence Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$432K	Buy	+6,118	New	+$330K	0.02%	471
2026 Q1	–	Sell	-4,350	Closed	-$256K	–	896
2025 Q4	$256K	Hold	4,350	–	–	0.02%	655
2025 Q3	$242K	Hold	4,350	–	–	0.01%	696
2025 Q2	$224K	Hold	4,350	–	–	0.01%	713
2025 Q1	$255K	Hold	4,350	–	–	0.02%	638
2024 Q4	$313K	Sell	4,350 -2,750	-39%	-$202K	0.02%	554
2024 Q3	$568K	Hold	7,100	–	–	0.04%	386
2024 Q2	$449K	Hold	7,100	–	–	0.03%	419
2024 Q1	$500K	Hold	7,100	–	–	0.03%	408
2023 Q4	$548K	Sell	7,100 -3,330	-32%	-$219K	0.04%	368
2023 Q3	$710K	Buy	+10,430	New	+$824K	0.06%	285
2023 Q1	–	Sell	-5,360	Closed	-$444K	–	789
2022 Q4	$444K	Hold	5,360	–	–	0.04%	411
2022 Q3	$381K	Hold	5,360	–	–	0.04%	427
2022 Q2	$464K	Hold	5,360	–	–	0.04%	363
2022 Q1	$580K	Hold	5,360	–	–	0.04%	337
2021 Q4	$693K	Buy	+5,360	New	+$657K	0.05%	307

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Everence Capital Management's TECH Position: Q2 2026 in Review

Everence Capital Management opened a new position in Bio-Techne (TECH) in Q2 2026: 6,118 shares worth $432K. The stake represents 0.02% of the portfolio and ranks #471 among its holdings. This is a return to the name: Everence Capital Management previously reported a position in TECH as recently as Q4 2025.

Everence Capital Management first reported a position in TECH in Q4 2021 and has held it in 16 quarters since. The position peaked at $710K in Q3 2023. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Everence Capital Management held 6,118 shares of Bio-Techne worth $432K as of Q2 2026.
Bio-Techne was a new Everence Capital Management position in Q2 2026.
Bio-Techne made up 0.02% of Everence Capital Management's portfolio in Q2 2026, its #471 holding.
Everence Capital Management first reported a position in Bio-Techne in Q4 2021 and has held it in 16 quarters since.
Everence Capital Management's Bio-Techne position peaked at $710K in Q3 2023.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.